Home » SANOFI PASTEUR TO INCREASE U.S. INFLUENZA VACCINE CAPACITY WITH CONSTRUCTION OF NEW PLANT
SANOFI PASTEUR TO INCREASE U.S. INFLUENZA VACCINE CAPACITY WITH CONSTRUCTION OF NEW PLANT
July 21, 2005
Work officially began today on the construction of a new sanofi pasteur manufacturing facility that will expand the ability of the United States to produce influenza vaccine for both routine influenza immunization and in case of a global influenza pandemic. Sanofi pasteur is the vaccines business of the sanofi-aventis. Pennsylvania Governor Edward G. Rendell was joined by company executives, federal, state and local officials in breaking ground for sanofi pasteur's new 145,000 square-foot, $150 million manufacturing plant.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20656520&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct